Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Serum Antibody
100%
Enzyme-linked Immunosorbent Assay (ELISA)
100%
HPV16
100%
Virus-like
100%
Polymerase Chain Reaction
27%
Human Papillomavirus
27%
Virion
18%
Cervical Cancer
18%
Genital
18%
Human Papillomavirus Types
18%
Human Papillomavirus DNA
18%
High-risk Human Papillomavirus Infection
18%
HPV16 Infection
18%
Significant Risk Factors
9%
Low Risk
9%
Infected Individual
9%
Epitope
9%
IgG Antibody
9%
Structural Proteins
9%
Natural History
9%
Serologic Assays
9%
High-risk Human Papillomavirus (HR-HPV)
9%
High-risk Women
9%
Papillomavirus Infections
9%
Genital Infection
9%
HPV6
9%
Severe Dysplasia
9%
Insect Cells
9%
HPV18
9%
High-risk Types
9%
IgG Antibody Response
9%
Recombinant Baculovirus
9%
HPV31
9%
Nucleic Acid-based Methods
9%
VirA
9%
DNA Bases
9%
Immunology and Microbiology
Enzyme-Linked Immunosorbent Assay
100%
Human Papillomavirus Type 16
100%
Antibody Blood Level
100%
Virus-Like Particle
100%
Wart Virus
76%
Immunoadsorption
76%
Infectious Disease
46%
Infection
46%
Polymerase Chain Reaction
23%
Virion
15%
Epitope
7%
Immunoglobulin G
7%
Baculoviridae
7%
Human Papillomavirus Type 18
7%
Immunoglobulin G Antibody
7%
Antigen
7%
Insect Cell
7%
Human Papillomavirus Type 31
7%
Human Papillomavirus Type 6
7%
Structural Protein
7%